Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Decreased pulse rate01:14

Decreased pulse rate

933
Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
933
Decreasing Function01:27

Decreasing Function

312
A decreasing function describes a relationship where the output consistently declines as the input increases. This means that for any two input values, if one is greater than the other, the corresponding output is smaller. Mathematically, a function f is decreasing on an interval I if for every x1 < x2​ in I, f (x1) > f (x2). This type of behavior is visually identified on a graph that slopes downward from left to right.The nature of a function can be analyzed by calculating...
312
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Decreased Body Temperature01:29

Decreased Body Temperature

1.1K
A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
1.1K
Concentration and Rate Law03:03

Concentration and Rate Law

40.6K
The rate of a reaction is affected by the concentrations of reactants. Rate laws (differential rate laws) or rate equations are mathematical expressions describing the relationship between the rate of a chemical reaction and the concentration of its reactants.
For example, in a generic reaction aA + bB ⟶ products, where a and b are stoichiometric coefficients, the rate law can be written as:
40.6K
Reaction Rate02:53

Reaction Rate

65.6K
The rate of reaction is the change in the amount of a reactant or product per unit time. Reaction rates are therefore determined by measuring the time dependence of some property that can be related to reactant or product amounts. Rates of reactions that consume or produce gaseous substances, for example, are conveniently determined by measuring changes in volume or pressure.
The mathematical representation of the change in the concentration of reactants and products, over time, is the rate...
65.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Profiling the molecular and physiological effects of senolytic treatment on aged mice identifies immune, fibrotic and metabolic remodeling.

Nature aging·2026
Same author

Should we prioritize proton beam therapy before making a decision on orthotopic liver transplantation for unresectable hepatoblastoma?

The Turkish journal of pediatrics·2026
Same author

The relationship between urine output and time to methotrexate clearance in pediatric leukemia patients receiving high-dose methotrexate therapy.

BMC cancer·2025
Same author

BK Polyomavirus-Associated Nephropathy and Hemorrhagic Cystitis in Transplant Recipients-What We Understand and What Remains Unclear.

Viruses·2025
Same author

Prenatal diagnosis and counseling of Emanuel syndrome: Two case reports.

Taiwanese journal of obstetrics & gynecology·2025
Same author

Chimeric Antigen Receptor Cell Therapy: Empowering Treatment Strategies for Solid Tumors.

Current issues in molecular biology·2025

Related Experiment Video

Updated: Feb 11, 2026

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

12.9K

Combined Immunotherapy (OK-432, IL-2) With Chemotherapy Decrease the Recurrence Rate in Advanced Ovarian Cancer.

Yi-Lun Wang1, Hsiu-Huei Peng2, Sheng-Yuan Su2

  • 11 Chang Gung University College of Medicine and Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan.

Reproductive Sciences (Thousand Oaks, Calif.)
|April 17, 2018
PubMed
Summary
This summary is machine-generated.

Immunochemotherapy (IMCT) combining picibanil (OK-432) and interleukin-2 (IL-2) with chemotherapy significantly reduced recurrence rates in advanced ovarian cancer patients. This novel approach offers a promising alternative to traditional chemotherapy post-surgery.

Keywords:
advanced ovarian cancerchemotherapyimmunotherapyinterleukin-2 (IL-2)picibanil (OK-432)

More Related Videos

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

2.7K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

11.0K

Related Experiment Videos

Last Updated: Feb 11, 2026

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

12.9K
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

2.7K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

11.0K

Area of Science:

  • Oncology
  • Immunology
  • Cancer Therapy

Background:

  • Advanced ovarian cancer treatment typically involves debulking surgery and chemotherapy.
  • Novel therapeutic strategies are needed to improve patient outcomes and reduce recurrence rates.

Purpose of the Study:

  • To evaluate the efficacy of immunochemotherapy (IMCT) combined with picibanil (OK-432) and interleukin-2 (IL-2) plus traditional chemotherapy.
  • To compare IMCT with traditional chemotherapy in patients with advanced ovarian cancer.

Main Methods:

  • Retrospective review of 51 advanced ovarian cancer patients (2007-2015).
  • Comparison between an IMCT group (n=26) and a traditional chemotherapy group (n=25) post-debulking surgery.
  • Analysis of recurrence rates, diagnosis-to-recurrence duration, and laboratory markers (blood counts, CA-125).

Main Results:

  • The IMCT group exhibited a significantly lower recurrence rate (53.8%) compared to the traditional chemotherapy group (88%; P = .0128).
  • Higher white blood cell, absolute neutrophil, and absolute lymphocyte counts were observed in the IMCT group at 1 month post-treatment.
  • Lower cancer antigen 125 (CA-125) levels and higher absolute lymphocyte counts (ALCs) were associated with non-recurrence.

Conclusions:

  • Combined IMCT and chemotherapy demonstrate a reduced recurrence rate in advanced ovarian cancer compared to traditional chemotherapy after debulking surgery.
  • IMCT shows potential as an effective treatment strategy for advanced ovarian cancer, warranting further investigation.